nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters
|
Jurisic, Vladimir |
|
2008 |
25 |
3 |
p. 315-322 |
artikel |
2 |
A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
|
Karapanagiotou, Eleni M. |
|
2008 |
25 |
3 |
p. 303-308 |
artikel |
3 |
Bisphosphonate treatment and radiotherapy in metastatic breast cancer
|
Ural, A. Ugur |
|
2008 |
25 |
3 |
p. 350-355 |
artikel |
4 |
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer
|
Acar, Ayla |
|
2007 |
25 |
3 |
p. 279-283 |
artikel |
5 |
Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study
|
Yilmaz, Mehmet Halit |
|
2007 |
25 |
3 |
p. 257-263 |
artikel |
6 |
Differentiation syndrome in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene
|
DiNardo, Courtney D. |
|
2008 |
25 |
3 |
p. 299-302 |
artikel |
7 |
Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases
|
Tas, Faruk |
|
2008 |
25 |
3 |
p. 346-349 |
artikel |
8 |
Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma
|
Shen, Shi-Qiang |
|
2008 |
25 |
3 |
p. 341-345 |
artikel |
9 |
Functional characterization of the HOXB13 promoter region
|
Cross, Deanna S. |
|
2007 |
25 |
3 |
p. 287-293 |
artikel |
10 |
Inhibition of 7,12-dimethylbenzanthracene-induced skin tumors by a nutrient mixture
|
Roomi, M. W. |
|
2008 |
25 |
3 |
p. 333-340 |
artikel |
11 |
Oral premedication for the prevention of hypersensitivity reactions to paclitaxel
|
Zidan, Jamal |
|
2008 |
25 |
3 |
p. 274-278 |
artikel |
12 |
Primary mediastinal large B-cell lymphoma mimicking liposarcoma
|
Huang, C. T. |
|
2007 |
25 |
3 |
p. 284-286 |
artikel |
13 |
Prostate cancer
|
Madajewicz, Stefan |
|
2008 |
25 |
3 |
p. 331-332 |
artikel |
14 |
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastases
|
Dincer, Murat |
|
2008 |
25 |
3 |
p. 356-359 |
artikel |
15 |
Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified
|
Avilés, Agustin |
|
2008 |
25 |
3 |
p. 360-364 |
artikel |
16 |
Ronald M. Bukowski, Andrew C. Novick (eds): Clinical management of renal tumors
|
Dutcher, Janice P. |
|
2008 |
25 |
3 |
p. 365-366 |
artikel |
17 |
Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia
|
Alexandrescu, Doru T. |
|
2008 |
25 |
3 |
p. 309-314 |
artikel |
18 |
Systematic review to establish the safety profiles for direct and indirect inhibitors of p38 Mitogen-activated protein kinases for treatment of cancer
|
Noel, J. Kay |
|
2008 |
25 |
3 |
p. 323-330 |
artikel |
19 |
The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma
|
Ozturk, Banu |
|
2007 |
25 |
3 |
p. 269-273 |
artikel |
20 |
Understanding and management of male breast cancer: a critical review
|
Pant, Kartikeya |
|
2007 |
25 |
3 |
p. 294-298 |
artikel |
21 |
Unusual presentation of metastatic hepatocellular carcinoma in the nasal septum: a case report and review of the literature
|
Chang, Ching-Wei |
|
2007 |
25 |
3 |
p. 264-268 |
artikel |